These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 15953079

  • 1. Unusual cutaneous involvement during plasma cell leukaemia phase in a multiple myeloma patient after treatment with thalidomide: a case report and review of the literature.
    Alexandrescu DT, Koulova L, Wiernik PH.
    Clin Exp Dermatol; 2005 Jul; 30(4):391-4. PubMed ID: 15953079
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Leukocytoclastic vasculitis due to thalidomide in multiple myeloma.
    Yildirim ND, Ayer M, Küçükkaya RD, Alpay N, Mete O, Yenerel MN, Yavuz AS, Nalçaci M.
    Jpn J Clin Oncol; 2007 Sep; 37(9):704-7. PubMed ID: 17709605
    [Abstract] [Full Text] [Related]

  • 5. Isolated thrombocytopenia induced by thalidomide in a patient with multiple myeloma: case report and review of literature.
    Prasad HK, Kaushal V, Mehta P.
    Am J Hematol; 2007 Sep; 82(9):855-7. PubMed ID: 17570510
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Low-dose thalidomide in refractory and relapsing multiple myeloma].
    Radocha J, Maisnar V.
    Vnitr Lek; 2007 Feb; 53(2):129-34. PubMed ID: 17419173
    [Abstract] [Full Text] [Related]

  • 8. Multiple bulky cutaneous plasmacytomas with CNS relapse without bone marrow involvement during the course of a lambda light chain myeloma.
    Serefhanoglu S, Haznedaroglu IC, Goker H, Buyukasik Y, Ozcebe OI.
    Onkologie; 2009 Nov; 32(11):662-4. PubMed ID: 19887870
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma.
    Palumbo A, Avonto I, Bruno B, Ambrosini MT, Bringhen S, Cavallo F, Falco P, Boccadoro M.
    Eur J Haematol; 2006 Apr; 76(4):273-7. PubMed ID: 16519697
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia.
    Ballanti S, Mastrodicasa E, Bolli N, Lotti F, Capolsini I, Berchicci L, Merigiola C, Giordano G, Tabilio A.
    Nat Clin Pract Oncol; 2007 Dec; 4(12):722-5. PubMed ID: 18037876
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.